919016-93-6 Usage
Uses
Used in Organic Synthesis:
4-(3-Fluoro-phenyl)-tetrahydro-pyran-4-carboxylic acid is used as a synthetic intermediate for the preparation of various organic compounds. Its unique structure allows for versatile chemical reactions, facilitating the synthesis of a wide range of molecules with potential applications in different industries.
Used in Medicinal Chemistry:
In the pharmaceutical industry, 4-(3-Fluoro-phenyl)-tetrahydro-pyran-4-carboxylic acid is used as a key building block in the development of new drugs. Its incorporation into molecular frameworks can lead to the discovery of novel bioactive compounds with therapeutic potential. The specific properties and applications of 4-(3-FLUORO-PHENYL)-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID in medicinal chemistry would require further investigation and optimization in a laboratory setting to fully realize its potential.
Check Digit Verification of cas no
The CAS Registry Mumber 919016-93-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,9,0,1 and 6 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 919016-93:
(8*9)+(7*1)+(6*9)+(5*0)+(4*1)+(3*6)+(2*9)+(1*3)=176
176 % 10 = 6
So 919016-93-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H13FO3/c13-10-3-1-2-9(8-10)12(11(14)15)4-6-16-7-5-12/h1-3,8H,4-7H2,(H,14,15)
919016-93-6Relevant articles and documents
PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS
-
Page/Page column 81; 87-88; 136, (2021/04/10)
The present invention relates to novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided herein can act as prostaglandin E2 (PGE2) EP4 receptor antagonists, which renders them highly advantageous for use in therapy, particularly in the treatment or prevention of cancer, a neovascular eye disease, inflammatory pain, or an inflammatory disease, such as, e.g., multiple sclerosis, rheumatoid arthritis or endometriosis.
NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF
-
, (2008/12/06)
Compounds of Formula (I) and Formula (II) are useful as inhibitors of HIF prolyl hydroxylases. Compounds of Formula(I) and Formula (II) have the following structures, where the definitions of the variables are provided herein.